Literature DB >> 22302778

Feasibility, reliability, and validity of the Pediatric Quality of Life Inventory ™ generic core scales, cancer module, and multidimensional fatigue scale in long-term adult survivors of pediatric cancer.

Rhonda S Robert1, Raheem J Paxton, Shana L Palla, Grace Yang, Martha A Askins, Shaini E Joy, Joann L Ater.   

Abstract

BACKGROUND: Most health-related quality of life assessments are designed for either children or adults and have not been evaluated for adolescent and young adult survivors of pediatric cancer. The objective of this study was to examine the feasibility, reliability, and validity of the Pediatric Quality of Life Inventory (PedsQL ™ Generic Core Scales, Cancer Module, and Multidimensional Fatigue Scale in adult survivors of pediatric cancer.
METHODS: Adult survivors (n = 64; Mean age 35 year old; >2 years after treatment) completed the PedsQL™ Generic Core Scales, Cancer Module, and Multidimensional Fatigue Scale. Feasibility was examined with floor and ceiling effects; and internal consistency was determined by Cronbach's coefficient alpha calculations. Inter-factor correlations were also assessed.
RESULTS: Significant ceiling effects were observed for the scales of social function, nausea, procedural anxiety, treatment anxiety, and communication. Internal consistency for all subscales was within the recommended ranges (α ≥ 0.70). Moderate to strong correlations between most Cancer Module and Generic Core Scales (r = 0.25 to r = 0.76) and between the Multidimensional Fatigue Scale and Generic Core Scales (r = 0.37 to r = 0.73).
CONCLUSIONS: The PedsQL™ Generic Core Scales, Cancer Module, and Multidimensional Fatigue Scale appear to be feasible for an older population of pediatric cancer survivors; however, some of the Cancer Module Scales (nausea, procedural/treatment anxiety, and communication) were deemed not relevant for long-term survivors. More information is needed to determine whether the issues addressed by these modules are meaningful to long-term adult survivors of pediatric cancers.
Copyright © 2012 Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22302778      PMCID: PMC3358502          DOI: 10.1002/pbc.24099

Source DB:  PubMed          Journal:  Pediatr Blood Cancer        ISSN: 1545-5009            Impact factor:   3.167


  34 in total

Review 1.  Quality of life in young adult survivors of childhood cancer.

Authors:  N E Langeveld; H Stam; M A Grootenhuis; B F Last
Journal:  Support Care Cancer       Date:  2002-10-24       Impact factor: 3.603

2.  The PedsQL 4.0 Generic Core Scales Young Adult Version: feasibility, reliability and validity in a university student population.

Authors:  James W Varni; Christine A Limbers
Journal:  J Health Psychol       Date:  2009-05

3.  The Minneapolis-Manchester Quality of Life instrument: reliability and validity of the Adolescent Form.

Authors:  Smita Bhatia; Meriel E M Jenney; Monica K Bogue; Todd H Rockwood; James H Feusner; Debra L Friedman; Leslie L Robison; Robert L Kane
Journal:  J Clin Oncol       Date:  2002-12-15       Impact factor: 44.544

4.  PedsQL 4.0: reliability and validity of the Pediatric Quality of Life Inventory version 4.0 generic core scales in healthy and patient populations.

Authors:  J W Varni; M Seid; P S Kurtin
Journal:  Med Care       Date:  2001-08       Impact factor: 2.983

5.  Health status and health-related quality of life in long-term adult survivors of pediatric solid tumors.

Authors:  D B Crom; D K Chathaway; E A Tolley; R K Mulhern; M M Hudson
Journal:  Int J Cancer Suppl       Date:  1999

6.  Quality of life in childhood cancer survivors.

Authors:  Brad J Zebrack; Mark A Chesler
Journal:  Psychooncology       Date:  2002 Mar-Apr       Impact factor: 3.894

7.  The PedsQL in pediatric cancer: reliability and validity of the Pediatric Quality of Life Inventory Generic Core Scales, Multidimensional Fatigue Scale, and Cancer Module.

Authors:  James W Varni; Tasha M Burwinkle; Ernest R Katz; Kathy Meeske; Paige Dickinson
Journal:  Cancer       Date:  2002-04-01       Impact factor: 6.860

8.  The PedsQL 4.0 Generic Core Scales: sensitivity, responsiveness, and impact on clinical decision-making.

Authors:  James W Varni; Michael Seid; Tara Smith Knight; Karen Uzark; Ilona S Szer
Journal:  J Behav Med       Date:  2002-04

9.  Long-term sequelae in children treated for brain tumors: impairments, disability, and handicap.

Authors:  Marta Macedoni-Luksic; Berta Jereb; Lupco Todorovski
Journal:  Pediatr Hematol Oncol       Date:  2003-03       Impact factor: 1.969

10.  Cancer survivors in the United States: age, health, and disability.

Authors:  Maria Hewitt; Julia H Rowland; Rosemary Yancik
Journal:  J Gerontol A Biol Sci Med Sci       Date:  2003-01       Impact factor: 6.053

View more
  15 in total

1.  Health-related quality of life of adolescent and young adult patients with cancer in the United States: the Adolescent and Young Adult Health Outcomes and Patient Experience study.

Authors:  Ashley Wilder Smith; Keith M Bellizzi; Theresa H M Keegan; Brad Zebrack; Vivien W Chen; Anne Victoria Neale; Ann S Hamilton; Margarett Shnorhavorian; Charles F Lynch
Journal:  J Clin Oncol       Date:  2013-05-06       Impact factor: 44.544

2.  Optimizing the measurement of health-related quality of life in adolescents and young adults with cancer.

Authors:  John M Salsman; Suzanne C Danhauer; Justin B Moore; Mollie R Canzona; David E Victorson; Bradley J Zebrack; Bryce B Reeve
Journal:  Cancer       Date:  2020-09-10       Impact factor: 6.860

3.  Assessment of Quality of Life in Young Patients with Single Ventricle after the Fontan Operation.

Authors:  Karen Uzark; Victor Zak; Peter Shrader; Brian W McCrindle; Elizabeth Radojewski; James W Varni; Kaitlyn Daniels; Jill Handisides; Kevin D Hill; Linda M Lambert; Renee Margossian; Victoria L Pemberton; Wyman W Lai; Andrew M Atz
Journal:  J Pediatr       Date:  2015-12-10       Impact factor: 4.406

4.  Health-related quality of life, lifestyle behaviors, and intervention preferences of survivors of childhood cancer.

Authors:  Hoda Badr; Joya Chandra; Raheem J Paxton; Joann L Ater; Diana Urbauer; Cody Scott Cruz; Wendy Demark-Wahnefried
Journal:  J Cancer Surviv       Date:  2013-06-08       Impact factor: 4.442

Review 5.  Patient-reported outcome measurement implementation in cancer survivors: a systematic review.

Authors:  Surbhi Singhal; James Dickerson; Michael J Glover; Mohana Roy; Michelle Chiu; Timothy Ellis-Caleo; Gavin Hui; Carla Tamayo; Nele Loecher; Hong-Nei Wong; Lauren C Heathcote; Lidia Schapira
Journal:  J Cancer Surviv       Date:  2022-05-23       Impact factor: 4.442

6.  Health-related quality of life in young adults in education, employment, or training: development of the Japanese version of Pediatric Quality of Life Inventory (PedsQL) Generic Core Scales Young Adult Version.

Authors:  Mei Kaneko; Iori Sato; Takafumi Soejima; Kiyoko Kamibeppu
Journal:  Qual Life Res       Date:  2014-02-14       Impact factor: 4.147

7.  Factorial invariance of pediatric patient self-reported fatigue across age and gender: a multigroup confirmatory factor analysis approach utilizing the PedsQL™ Multidimensional Fatigue Scale.

Authors:  James W Varni; A Alexander Beaujean; Christine A Limbers
Journal:  Qual Life Res       Date:  2013-02-20       Impact factor: 4.147

8.  Fatigue in adolescent and adult survivors of non-CNS childhood cancer: a report from project REACH.

Authors:  Natasha N Frederick; Lisa Kenney; Lynda Vrooman; Christopher J Recklitis
Journal:  Support Care Cancer       Date:  2016-04-27       Impact factor: 3.603

9.  Severe fatigue after treatment for childhood cancer.

Authors:  Sylvia van Deuren; Amilie Boonstra; Eline van Dulmen-den Broeder; Nicole Blijlevens; Hans Knoop; Jacqueline Loonen
Journal:  Cochrane Database Syst Rev       Date:  2020-03-03

Review 10.  Physical training interventions for children and teenagers affected by acute lymphoblastic leukemia and related treatment impairments.

Authors:  Carolina Simioni; Giorgio Zauli; Alberto M Martelli; Marco Vitale; Simona Ultimo; Daniela Milani; Luca M Neri
Journal:  Oncotarget       Date:  2018-03-30
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.